Claims
- 1. Nitrogen-containing heterocyclic compounds represented by the formula ##STR118## wherein Y represents ##STR119## wherein m is 1 or 2; R.sub.1 and R.sub.4, which may be the same or different, each represents a hydrogen atom, a lower alkyl group, or a lower alkenyl group; R.sub.2 and R.sub.3, which may be the same or different, each represents a hydrogen atom, a hydroxyl group, a lower alkanoyloxy group, a lower alkyl group or a lower alkenyl group; said R.sub.2 and R.sub.3 may further form together a double bond; R.sub.5 and R.sub.6, which may be the same or different, each represents a hydrogen atom, a halogen atom, a hydroxyl group, a nitro group, an amino group, a lower alkoxy group, a mono or di lower alkylamino group, or a lower alkyl group; said R.sub.5 and R.sub.6 may further form together a lower alkylenedioxy group; and R.sub.7 represents a hydrogen atom, a halogen atom, a lower alkanoyl group, a phenyl group, a phenyl lower alkyl group, a lower alkyl group, a hydroxy lower alkyl group, a di-lower alkylamino lower alkyl group, a pyrrolidino lower alkyl group, a piperidino lower alkyl group, a morpholine lower alkyl group, or a 4-lower alkylpiperazino lower alkyl group; and the pharmacologically acceptable non-toxic salts thereof.
- 2. The compounds as claimed in claim 1 wherein R.sub.2 and R.sub.3 are a hydrogen atom or a lower alkyl group, and the pharmacologically acceptable non-toxic salts thereof.
- 3. A compound as claimed in claim 1 which is 7-chloro-5-oxo-2,3-dihydro-5H-thiazolo[3,2-b]isoquinoline-1-oxide and the pharmacologically acceptable non-toxic salts thereof.
- 4. A compound as claimed in claim 1 which is 7-chloro-3-methyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-b]isoquinoline-1-oxide and the pharmacologically acceptable non-toxic salts thereof.
- 5. The compound as claimed in claim 1 wherein R.sub.2 and R.sub.3 are a hydrogen atom or a lower alkyl group, and R.sub.5 or R.sub.6 is a halogen atom.
- 6. The compound as claimed in claim 1 wherein R.sub.2 and R.sub.3 are a hydrogen atom or a lower alkyl group, and R.sub.5 or R.sub.6 is a mono or di lower alkylamino group.
- 7. A compound as claimed in claim 1 which is 5-oxo-2,3-dihydro-5H-thiazolo[3,2-b]isoquinoline-1-oxide and the pharmacologically acceptable non-toxic salts thereof.
- 8. A compound as claimed in claim 1 which is 5-oxo-5H-thiazolo[3,2-b]isoquinoline-1,1-dioxide and the pharmacologically acceptable non-toxic salts thereof.
- 9. A compound as claimed in claim 2 which is 5-oxo-2,3-dihydro-5H-thiazolo[3,2-b]isoquinoline-1,1-dioxide and the pharmacologically acceptable non-toxic salts thereof.
- 10. A compound as claimed in claim 5 which is 7-chloro-5-oxo-2,3-dihydro-5H-triazolo[3,2-b]isoquinoline-1,1-dioxide and the pharmacologically acceptable non-toxic salts thereof.
- 11. A compound as claimed in claim 5 which is 7-chloro-3-methyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-b]isoquinoline-1,1-dioxide and the pharmacologically acceptable non-toxic salts thereof.
- 12. A compound as claimed in claim 6 which is 7-dimethylamino-5-oxo-2,3-dihydro-5H-thiazolo[3,2-b]isoquinoline-1-oxide and the pharmacologically acceptable non-toxic salts thereof.
- 13. A compound as claimed in claim 5 which is 7-chloro-5-oxo-5H-thiazolo[3,2-b]isoquinoline-1,1-dioxide and the pharmacologically acceptable non-toxic salts thereof.
- 14. An analgesic antiinflammatory composition which contains a therapeutically effective amount of the compound of claim 1 and a pharmacologically acceptable diluent.
- 15. The pharmaceutical composition as claimed in claim 14 which contains 7-chloro-5-oxo-2,3-dihydro-5H-thiazolo[3,2-b]isoquinoline-1-oxide and a pharmacologically acceptable diluent.
- 16. The pharmaceutical composition as claimed in claim 14 which contains 7-chloro-3-methyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-b]isoquinoline-1-oxide and a pharmacologically acceptable diluent.
- 17. A method of producing strong analgesic antiinflammatory activity which comprises administering to a host an effective amount of a compound of claim 1.
Priority Claims (2)
Number |
Date |
Country |
Kind |
51-157867 |
Dec 1976 |
JPX |
|
52-121666 |
Oct 1977 |
JPX |
|
Parent Case Info
This is a continuation of application Ser. No. 29,000, filed Apr. 11, 1979, now abandoned, which is a divisional of U.S. Pat. No. 861,980, filed Dec. 19, 1977, now U.S. Pat. No. 4,163,844 which issued Aug. 7, 1979.
Foreign Referenced Citations (1)
Number |
Date |
Country |
1960376 |
Jun 1971 |
DEX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
861980 |
Dec 1977 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
29000 |
Apr 1979 |
|